XML 51 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation

NOTE 18—STOCK-BASED COMPENSATION

2008 Equity Incentive Plan

Our 2008 Equity Incentive Plan, as amended (the “Plan”), authorizes us to issue up to 3.5 million shares of common stock, along with non-qualified stock options, stock appreciation rights, restricted stock and performance units to our officers, key employees, non-employee directors and consultants. At December 31, 2017, there were 1.7 million shares available for future grants under this Plan. No more than 600,000 shares may be used under the Plan as “full value” awards, which include restricted stock and performance stock units. It is our policy to issue shares from authorized but not issued shares upon the exercise of stock options.

During the first quarter of 2015, the company implemented a long-term incentive program for the benefit of certain members of company management. The program was designed to strengthen employee retention and to provide a more structured incentive program to stimulate improvement in future company results. Per the terms of the program, participants were granted, in 2015, 2016 and 2017, time value restricted stock units (“RSUs”), vesting ratably over a three-year time period, and performance restricted stock units (“PSUs”), with a three-year cliff vesting. Upon vesting, each restricted stock award is exchangeable for one share of the company’s common stock, with accrued dividends. The PSUs are categorized further into three individual categories whose vesting is contingent upon the achievement of certain targets as follows:

 

    40 percent of the PSUs vest upon certain Return on Invested Capital targets for 2017, 2016 and 2015 units

 

    40 percent of the PSUs vest upon certain Cumulative EPS targets for 2017 and 2016 units

 

    40 percent of the PSUs vest upon certain EBITDA margin targets for 2015 units

 

    20 percent of the PSUs vest upon certain market based Shareholder Return targets for 2017, 2016 and 2015 units

Other Awards

During 2014, we granted 132,455 restricted shares, including 50,000 shares vesting April 30, 2017, and 82,455 shares vesting on December 31, 2016 under an Executive Employment Agreement (the “Employment Agreement”). The fair value of each of these restricted shares was $19.44. These grants were made outside of the Plan as inducement grants in connection with the appointment of our current CEO and company President. Beginning in 2015, the CEO will be granted restricted stock unit awards each year under Superior’s 2008 Equity Incentive Plan, or any successor equity plan. Under the CEO’s Employment Agreement, time-vested restricted stock units will be granted each year with cliff vesting at the third fiscal year end following grant. The CEO will also be granted performance-vested restricted stock units each year, vesting based on company performance goals established by the independent compensation committee during the three fiscal years following the grant.

 

Options

Options are granted at not less than fair market value on the date of grant and expire no later than ten years after the date of grant. Options and restricted shares granted under this Plan generally require no less than a three-year ratable vesting period. Stock option activity in 2017 and 2016 are summarized in the following table:

 

     Outstanding      Weighted
Average
Exercise
Price
     Remaining
Contractual
Life in
Years
     Aggregate
Intrinsic
Value
 

Balance at December 31, 2015

     376,033      $ 18.89        3.6      $ 452,128  

Granted

     —        $ —          

Exercised

     (86,908    $ 18.77        

Canceled

     (24,750    $ 21.51        

Expired

     (32,750    $ 17.56        
  

 

 

          

Balance at December 31, 2016

     231,625      $ 18.88        3.1      $ 1,845,263  

Granted

     —          —          

Exercised

     (2,000    $ 16.76        

Canceled

     (6,000    $ 21.09        

Expired

     (78,000    $ 18.62        
  

 

 

          

Balance at December 31, 2017

     145,625      $ 18.96        
  

 

 

          

Options vested or expected to vest at December 31, 2017

     145,625      $ 18.96        2.0      $ —    
  

 

 

          

Exercisable at December 31, 2017

     145,625           
  

 

 

          

We received cash proceeds of less than $0.1 million, $1.6 million and $7.3 million from stock options exercised in 2017, 2016 and 2015, respectively. The total intrinsic value of options exercised was less than $0.1 million, $0.7 million and $0.8 million, for the years ended December 31, 2017, 2016 and 2015, respectively. Upon the exercise of stock options and the issuance of restricted stock awards, it is our policy to only issue shares from authorized common stock.

The aggregate intrinsic value represents the total pretax difference between the closing stock price on the last trading day of the reporting period and the option exercise price, multiplied by the number of in-the-money options. This is the amount that would have been received by the option holders had they exercised and sold their options on that day. This amount varies based on changes in the fair market value of our common stock. The closing price of our common stock on the last trading day of our fiscal year was $14.85.

Stock options outstanding at December 31, 2017 and 2016 are summarized in the following tables:

 

Range of

Exercise Prices

   

Options

Outstanding

at
12/31/2017

   

Weighted
Average
Remaining

Contractual
Life (in
Years)

    

Weighted
Average
Exercise

Price

    

Options

Exercisable

at
12/31/2017

    

Weighted
Average
Exercise

Price

 
$ 15.17       —       $ 15.75       29,375       1.6      $ 15.17        29,375      $ 15.17  
$ 15.76       —       $ 16.54       24,250       2.4      $ 16.32        24,250      $ 16.32  
$ 16.55       —       $ 19.65       22,000       4.5      $ 17.07        22,000      $ 17.07  
$ 19.66       —       $ 22.21       49,000       0.4      $ 21.84        49,000      $ 21.84  
$ 22.22       —       $ 22.57       21,000       3.4      $ 22.57        21,000      $ 22.57  
     

 

 

         

 

 

    
      145,625       2.0      $ 18.96        145,625      $ 18.96  
   

 

 

         

 

 

    

 

Range of

Exercise Prices

   

Options

Outstanding

at
12/31/2016

   

Weighted
Average
Remaining

Contractual
Life (in
Years)

    

Weighted
Average
Exercise

Price

    

Options

Exercisable

at
12/31/2016

    

Weighted
Average
Exercise

Price

 
$ 15.17       —       $ 16.54       54,625       3.0      $ 15.68        54,625      $ 15.68  
$ 16.55       —       $ 17.58       36,000       5.5      $ 16.95        36,000      $ 16.95  
$ 17.59       —       $ 20.20       54,000       2.3      $ 18.16        54,000      $ 18.16  
$ 20.21       —       $ 22.21       51,000       1.4      $ 21.84        51,000      $ 21.84  
$ 22.22       —       $ 22.57       36,000       4.4      $ 22.57        36,000      $ 22.57  
     

 

 

         

 

 

    
      231,625       3.1      $ 18.88        231,625      $ 18.88  
   

 

 

         

 

 

    

Restricted Stock Awards

Restricted stock awards, or “full value” awards, generally vest ratably over no less than a three-year period. Shares of restricted stock granted under the Plan are considered issued and outstanding at the date of grant, have the same dividend and voting rights as other outstanding common stock, are subject to forfeiture if employment terminates prior to vesting, and are expensed ratably over the vesting period. Dividends paid on the restricted shares granted under the Plan are non-forfeitable if the restricted shares do not ultimately vest. Restricted stock activity in 2017 and 2016 are summarized in the following table:

 

     Number
of Awards
     Weighted
Average
Grant
Date Fair
Value
     Weighted
Average
Remaining
Amortization
Period (in
Years)
 

Balance at December 31, 2015

     192,293      $ 19.20        1.7  

Granted

     —        $ —       

Vested

     (42,546    $ 18.47     

Canceled

     (5,452    $ 18.75     
  

 

 

       

Balance at December 31, 2016

     144,295      $ 19.43        0.5  

Granted

     —        $ —       

Vested

     (140,628    $ 19.43     

Canceled

     (3,667    $ 19.16     
  

 

 

       

Balance at December 31, 2017

     —        $ —          —    
  

 

 

       

 

Restricted Stock Units

Restricted stock unit activity in 2017 and 2016 are summarized in the following table:

 

     Number
of Awards
     Weighted
Average
Grant
Date Fair
Value
     Weighted
Average
Remaining
Amortization
Period (in
Years)
 

Balance at December 31, 2015

     53,323      $ 18.78        2.1  

Granted

     84,200      $ 23.71     

Vested

     (7,227    $ 18.78     

Canceled

     (2,729    $ 18.78     
  

 

 

       

Balance at December 31, 2016

     127,567      $ 22.03        1.7  

Granted

     131,656      $ 22.24     

Vested

     (67,889    $ 21.54     

Canceled

     (22,068    $ 22.95     
  

 

 

       

Balance at December 31, 2017

     169,266      $ 22.27        1.6  
  

 

 

       

Restricted Performance Stock Units

Restricted performance stock unit activity in 2017 and 2016 are summarized in the following table:

 

     Number
of Awards
     Weighted
Average
Grant
Date Fair
Value
     Weighted
Average
Remaining
Amortization
Period (in
Years)
 

Balance at December 31, 2015

     106,647      $ 18.78        2.0  

Granted

     127,139      $ 23.14     

Vested

     —        $ —       

Canceled

     (6,593    $ 19.92     
  

 

 

       

Balance at December 31, 2016

     227,193      $ 21.72        1.6  

Granted

     164,566      $ 22.39     

Vested

     (71,493    $ 19.00     

Added by performance factor

     4,268        19.00     

Canceled

     (84,860    $ 22.76     
  

 

 

       

Balance at December 31, 2017

     239,674      $ 22.58        1.7  
  

 

 

       

Stock Based Compensation

Stock-based compensation expense related to our equity incentive plans in accordance with U.S. GAAP was allocated as follows:

 

Year Ended December 31,

   2017      2016      2015  
(Thousands of dollars)                     

Cost of sales

   $ 452      $ 472      $ 370  

Selling, general and administrative expenses

     2,124        3,218        2,437  
  

 

 

    

 

 

    

 

 

 

Stock-based compensation expense before income taxes

     2,576        3,690        2,807  

Income tax benefit

     (970      (1,361      (1,044
  

 

 

    

 

 

    

 

 

 

Total stock-based compensation expense after income taxes

   $ 1,606      $ 2,329      $ 1,763  
  

 

 

    

 

 

    

 

 

 

 

As of December 31, 2017, a total of $2.5 million of unrecognized stock-based compensation expense related to non-vested awards is expected to be recognized over a weighted average period of approximately 1.6 years. There were no significant capitalized stock-based compensation costs at December 31, 2017, 2016 or 2015.